Archive for November, 2009

Scientists Call For Urgent Attention To The Global Burden Of Mental Disease

Vikram Patel

Vikram Patel

LONDON—The new Centre For Global Mental Health has been inaugurated at a meeting in London. It’s been formed through a partnership between two academic institutions: The London School of Hygiene and Tropical Medicine and King’s Health Partners—a consortium of top London teaching hospitals and King’s College, London. It focuses on improving the treatment and prevention of mental illness world-wide, but with a particular priority on low and middle income countries. The co-directors, Vikram Patel of the London School and Martin Prince from The Institute of Psychiatry, together with Benedetto Saraceno, Director of the Department of Mental Health and Substance Abuse at the World Health Organisation and Pamela Collins of the US National Institute of Mental Health discuss the issues being addressed by this new research organisation.

Urgent Need To Change Cancer Research Priorities: Global Cancer Fund; Prevention; Surgical Innovation; Trans-National Research

Richard Sullivan

Richard Sullivan

Richard Sullivan at ECCO15-ESMO34 on the need for cancer research which is more trans-national and for a Global Cancer Fund to prioritize prevention, surgical innovation, and more creative, outward branching research strategies to probe mechanisms such as metastasis.

Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality

Mieke Van Hemelrijck

Mieke Van Hemelrijck

Mieke Van Hemelrijck at ECCO15-ESMO34 on findings that cardiovascular mortality from heart failure and arrhythmia in addition to ischemic heart disease and myocardial infarction increased among patients treated with endocrine therapy—of whatever type—for their prostate cancer.

Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue!

Cornelis van de Velde

Cornelis van de Velde

Cornelis van de Velde at ECCO15-ESMO34 on the largest comparison of an aromatase inhibitor with tamoxifen as initial adjuvant therapy for patients with hormone receptor-positive breast cancer–analysis of results from the TEAM (Tamoxifen Exemestane Adjuvant Multinational) study reported at ECCO15-ESMO34.